Principal Investigator
Division of Thoracic Medicine
Division of Others-Lung Cancer
Division of General Internal Medicine
Division of Hematology & Oncology
Division of Thoracic Medicine
Division of General Internal Medicine
Division of General Internal Medicine
Division of Thoracic Medicine
Division of Hematology & Oncology
更新時間：2023-09-19
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Highlights
2 Involved in International conference committee of IASLC Asia and APSR and as an invited speaker in WCLC.
3 As a PI of phase I trials of BOS172738 (an novel RET inhibitor) in RET fusion NSCLC; phase I/II trial BA3021 in combination of nivoluma;
4 Initiate an investigator initiated trial about combination of pemetrexed, platinum, atezolizumab and bevacizumab in EGFR TKI failed T790M (-) EGFR mutant lung cancer.
5 Has been audited by USA FDA for registration trial.
Study Area
- Lung cancer
- Thoracic Oncology
- Pulmonary Medicine
Professional Experiences
Professor
Department of Internal Medicine, College of Medicine
2012- 迄今
Division Director
Division of Chest, Department of Internal Medicine
Attending Physician
Division of Chest, Department of Internal Medicine
1999- 迄今
Education
Graduate Institute of Clinical Medicine
PhD.
School of Medicine
M.S.
Clinical Trials List
2016
Total 394
-
I 84
-
I/II 34
-
II 89
-
II/III 13
-
III 162
-
IV 1
-
Others 11
Number of Studies by Scale
8件
Taiwan Multiple Center
Taiwan Single Center
5Cases
Taiwan Multiple Center
8Cases
Multi-Regional Multi-Center
422Cases
